Myriad Genetics Inc (NASDAQ:MYGN)

33.63
BATS BZX Real-Time Price
As of 11:46am ET
 +0.14 / +0.42%
Today’s Change
31.56
Today|||52-Week Range
42.50
-1.26%
Year-to-Date

Today’s Trading

Previous close33.49
Today’s open33.49
Day’s range33.13 - 34.03
Volume275,545
Average volume (3 months)920,552
Market cap$2.4B
Dividend yield--
Data as of 11:35am ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-37.29%
Earnings growth (next 5 years)+13.75%
Revenue growth (last year)+26.92%
P/E ratio23.4
Price/Sales3.31
Price/Book3.42

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc-3.29-4.68%
--Cosmo Pharmaceutical...+9.35+6.24%
LCILannett Company Inc-1.09-1.73%
THRXTheravance Inc-0.12-0.62%
Data as of 11:47am ET, 03/03/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.39
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account